BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET
SAN RAFAEL, Calif., Oct. 26, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET
PR Newswire
SAN RAFAEL, Calif., Oct. 26, 2026
SAN RAFAEL, Calif., Oct. 26, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, November 2, 2026, at 4:30 p.m. ET to discuss third quarter 2026 financial results and provide a general business update.
Dial-in Number
U.S. / Canada Dial-in Number: +1 833-461-5787
International Dial-in Number: +1 626-884-3620
Conference Call ID: 324 588 583
U.S. / Canada Replay Dial-in Number: +1 833-309-1852
International Replay Dial-in Number: +44 800 007 4044
Playback ID: 324 588 583
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.
|
Contacts: |
|
|
Investors |
Media |
|
Traci McCarty |
Marni Kottle |
|
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
|
(415) 455-7558 |
(650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2026-financial-results-conference-call-and-webcast-on-monday-november-2-2026-at-430pm-et-302918505.html
SOURCE BioMarin Pharmaceutical Inc.
